The effect of the metformin in preventing of the preeclampsia

Phase 3

Recruiting

• Conditions: on severe preeclampsia.; Mild to moderate pre-eclampsia, unspecified trimester; O14.00

• Registration Number: IRCT20210316050725N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 52

Inclusion Criteria

Non severe preeclampsia
Single pregnancy

Exclusion Criteria

Eclamsia
Severe reeclamsia
Renal failure
Insulin -treated diabet

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severe preeclampsia. Timepoint: Weekly untill term pregnancy. Method of measurement: Weekly visit , blood pressure assesment , laboratory assesment.

Secondary Outcome Measures

Name	Time	Method
Hypertension. Timepoint: Weekly visit. Method of measurement: with the help of mercury manometer.;Fetal growth. Timepoint: Weekly. Method of measurement: Ultrasound.;Elevated in liver enzyme. Timepoint: Weekly. Method of measurement: Laboratory.;Headache, blurred vision , pain in epigaster. Timepoint: weekly. Method of measurement: Biography.;Blood creatinine in mother. Timepoint: Weekly. Method of measurement: Laboratory.;Diabet in mother. Timepoint: Monthly. Method of measurement: Assesment of Fast blood sugar and 2 hours after meal.;Fetal health assessment tests. Timepoint: Weekly. Method of measurement: Non stress test and biophysical profile.;Proteinurea. Timepoint: Weekly. Method of measurement: By collecting urine 24 hours a day.